Huafon Chemical Co. (002064) Q3 2026 earnings summary

Executive summary

• Q3 revenue rose 27.60% YoY to ¥7.621B; attributable net income increased 134.01% to ¥1.119B, while 9M revenue and net income grew 20.31% and 112.24%, respectively.

• 9M operating cash flow was ¥2.030B, down 30.73% YoY, primarily as cash paid for purchases and services increased.

Financial highlights

• Q3 adjusted net income, excluding non-recurring items, was ¥1.050B, up 139.62% YoY; 9M adjusted net income was ¥3.023B, up 125.13%.

• 9M reported net income was ¥3.103B versus ¥1.471B a year earlier; total non-recurring gains were ¥78.765M for 9M and ¥68.736M for Q3.

• Q3 basic and diluted EPS were both ¥0.23, up 130.00% YoY; 9M EPS was ¥0.63, up 117.24%.

• 9M operating revenue was ¥21.788B; operating costs were ¥18.390B, including ¥17.063B in operating costs of sales.

Key financial ratios and metrics

• 9M weighted average ROE was 10.83%, up 5.37 percentage points YoY; Q3 ROE was 3.81%, up 2.04 percentage points YoY.

• Total assets were ¥38.398B at Sept. 30, up 4.11% from year-end 2025; equity attributable to parent shareholders was ¥29.151B, up 6.63%.

• 9M net cash from operating activities was ¥2.030B, compared with ¥2.931B in the prior-year period.